HIV Diagnostics Test Market, by Test type (Screening, Differentiation & Confirmation Test, and Monitoring Test) and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2

HIV Diagnostics Test Market, by Test type (Screening, Differentiation & Confirmation Test, and Monitoring Test) and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Human immunodeficiency virus (HIV) is an infection that attacks the body's immune system, specifically the white blood cells called CD4 cells. HIV destroys these CD4 cells, weakening a person’s immunity against opportunistic infections, such as tuberculosis and fungal infections, severe bacterial infections and some cancers. The World Health Organization (WHO) recommends that every person who may be at risk of HIV should access testing. People at increased risk of acquiring HIV should seek comprehensive and effective HIV prevention, testing and treatment services. HIV diagnostics plays a major role in HIV prevention, treatment, care, and other support services. The diagnosis of HIV include testing services in health-care facilities, and wide range of community-based approaches along with HIV self-testing.

Market Dynamics

The increasing prevalence of HIV infections globally is expected to drive the market growth in the forecast period. For instance, according to the Pan American Health Organization (PAHO): 2020, the number of HIV infections increased by 21% from 2010 and 2019 in Latin America. According to the same source, the number of annual new infections continued to rise, reaching 120,000 in 2019. According to UNAIDS: AIDSinfo: 2018, in India, around 2.1 million people were suffering from HIV during 2017, making it the third-largest HIV epidemic in the world. Furthermore, as per UNAIDS: 2017; India’s HIV epidemic had slowed down, as HIV infections declined by 27% and AIDS-related deaths reduced by more than 56% between 2010 and 2017. However, in 2017, new infections increased to 88,000 from 80,000 and AIDS-related deaths increased to 69,000 from 62,000, from the year 2010, in India.

Key features of the study:

• This report provides an in-depth analysis of the global HIV diagnostics test market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global HIV diagnostics test market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
• Key companies covered as a part of this study include Abbott, Bio-Rad Laboratories, Inc., Hologic, Inc., Siemens Healthineers, Roche AG, Beckman Coulter Inc., OraSure Technologies, Inc., Becton, Dickinson and Company, Merck KGaA, Chembio Diagnostic Systems, Inc., Zyomyx Incorporation, Bristol –Myers Squibb, Janssen Pharmaceutica NV, QIAGEN N.V., and ViiV Healthcare Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global HIV diagnostics test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global HIV diagnostics test market

Detailed Segmentation:

• Global HIV Diagnostics Test Market, By Test Type:
• Screening
• Third Generation (Antibody Test)
• Laboratory-based
• Point-of-Care
• Fourth Generation (Antibody Test)
• Laboratory-based
• Point-of-Care
• Others
• Differentiation & Confirmation Test
• Monitoring Test
• CD4 Test
• Viral Load Tests
• Global HIV Diagnostics Test Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Country/Region
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Abbott
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Bio-Rad Laboratories, Inc.
• Hologic, Inc.
• Siemens Healthineers
• Roche AG
• Beckman Coulter Inc.
• OraSure Technologies, Inc.
• Becton, Dickinson and Company
• Merck KGaA
• Chembio Diagnostic Systems, Inc.
• Zyomyx Incorporation
• Bristol –Myers Squibb
• Janssen Pharmaceutica NV
• QIAGEN N.V.
• ViiV Healthcare Ltd.

“*” marked represents similar segmentation in other categories in the respective section.